Novartis nominates its own to Alcon board
This article was originally published in Scrip
Executive Summary
Novartis has responded to Alcon's objections to its proposed takeover of the eye-care specialist by nominating three previous employees to replace the Nestlé-nominated members that currently sit on the board.